The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2016

Filed:

Apr. 06, 2011
Applicants:

Stewart Abbot, Warren, NJ (US);

James W. Edinger, Belford, NJ (US);

Aleksandar Francki, Annandale, NJ (US);

Robert J. Hariri, Bernardsville, NJ (US);

Vladimir Jankovic, New York, NY (US);

Aleksandr Kaplunovsky, Budd Lake, NJ (US);

Kristen Labazzo, Springfield, NJ (US);

Eric Law, East Brunswick, NJ (US);

Neerav D. Padliya, Scotch Plains, NJ (US);

Jennifer Paredes, Bloomfield, NJ (US);

Jia-lun Wang, Cherry Hill, NJ (US);

Inventors:

Stewart Abbot, Warren, NJ (US);

James W. Edinger, Belford, NJ (US);

Aleksandar Francki, Annandale, NJ (US);

Robert J. Hariri, Bernardsville, NJ (US);

Vladimir Jankovic, New York, NY (US);

Aleksandr Kaplunovsky, Budd Lake, NJ (US);

Kristen Labazzo, Springfield, NJ (US);

Eric Law, East Brunswick, NJ (US);

Neerav D. Padliya, Scotch Plains, NJ (US);

Jennifer Paredes, Bloomfield, NJ (US);

Jia-Lun Wang, Cherry Hill, NJ (US);

Assignee:

ANTHROGENESIS CORPORATION, Warren, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/50 (2015.01); A61K 9/00 (2006.01); A61L 27/36 (2006.01); A61L 27/38 (2006.01); C12N 5/073 (2010.01); A61K 35/28 (2015.01);
U.S. Cl.
CPC ...
A61K 35/50 (2013.01); A61K 9/0019 (2013.01); A61K 9/0085 (2013.01); A61K 35/28 (2013.01); A61L 27/3633 (2013.01); A61L 27/3683 (2013.01); A61L 27/3808 (2013.01); A61L 27/3886 (2013.01); A61L 27/3895 (2013.01); C12N 5/0605 (2013.01);
Abstract

Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.


Find Patent Forward Citations

Loading…